• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number PAH110502E
Device Problems Material Fragmentation (1261); Separation Failure (2547)
Patient Problem Stenosis (2263)
Event Date 02/23/2021
Event Type  Injury  
Manufacturer Narrative
The patient age was asked but not provided.The device remains implanted, but the delivery catheter was requested and received for further investigation.A review of the manufacturing records indicated the lot met pre-release manufacturing specifications.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
It was reported to gore that patient underwent endovascular treatment for a stenosis in the iliac artery with a gore® viabahn® endoprosthesis with propaten bioactive surface (viabahn-device).It was stated that deployment was initiated, and the viabahn-device deployed but began to stuck in the last 5-10 mm.The deployment line could not be pulled anymore and the prosthesis was not deployed over the whole length.It was reported that after a bit of manipulation the viabahn-device was deployed completely.The deployment line came out of the sheath, but was still fixed at the prosthesis.The catheter could be removed and the physician tried to remove the deployment line, but with no success.It was stated that an additional surgery was needed.With a retroperitoneal access technique the deployment line could be removed and the patient is doing fine.
 
Manufacturer Narrative
Product investigation report conclusion: the specific cause of this complaint could not be determined.A product history review was conducted for the vsx device in this complaint, and the review of the manufacturing records indicated the lot met pre-release manufacturing specifications.The investigation confirms both a fraying and a cut deployment line.The complaint description also confirms partial deployment with deployment line fragments remaining in the patient with the implanted endoprosthesis.There are possible design and manufacturing causes for these failure modes which are related to the deployment line, but the specific cause is unable to be established.
 
Manufacturer Narrative
Updated section b1 to include 'product problem (e.G., defects/malfunctions)'.Updated section h6 to include component code 'device deployer, 788'.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key11513042
MDR Text Key240597150
Report Number2017233-2021-01773
Device Sequence Number1
Product Code NIP
UDI-Device Identifier00733132627752
UDI-Public(01)00733132627752(17)221227
Combination Product (y/n)Y
Reporter Country CodeGM
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 04/13/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/18/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/27/2022
Device Catalogue NumberPAH110502E
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/11/2021
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/07/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/28/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
11FR TERUMO INTRODUCER SHEATH.; 11FR TERUMO INTRODUCER SHEATH
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-